2 terminated. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Terminated 2 |
Follow VS-5584: new trials by email Literature Review of VS-5584 trials Research Report on VS-5584
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 1 Dose Escalation Study of VS-5584 Administered in Combination With VS-6063, in Subjects With Relapsed Malignant Mesothelioma VS-5584 and VS-6063 - Relapsed Malignant Mesothelioma | Phase 1 | Terminated | Verastem, Inc. | 21 | 2015-01-01 | 2017-01-30 |
| Phase I Dose Escalation Study of VS-5584 in Subjects With Advanced Non-Hematologic Malignancies or Lymphoma VS-5584 - Non Hematologic Cancers, Metastatic Cancer | Phase 1 | Terminated | Verastem, Inc. | 75 | 2013-11-01 | 2017-01-27 |
Lymphoma (1) · Mesothelioma, Malignant (1) · Neoplasm Metastasis (1)
Verastem, Inc. (2)
United Kingdom (2) · United States (2)
Hagop Youssoufian (1) · Hagop Youssoufian, MD (1)